BioSpace News Archive

Bio NC

K4Connect Closes $12 Million Series B Round of Funding Led by AXA Venture Partners

Global venture fund backed by financial and insurance powerhouse AXA invests in senior living’s most advanced technology solutions company

October 23, 2018
·
4 min read
Business

Edwards Comments On German Court Decision

The injunction will only become effective if Boston Scientific enforces it and provides a bond of €10 million.

October 23, 2018
·
2 min read
Business

Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018

Conference call Wednesday, October 31, 2018 to discuss the Company’s financial results and provide a general business update.

October 23, 2018
·
1 min read
Drug Development

Enanta Pharmaceuticals Announces Positive Phase 1 Results and Initiation of Phase 2a Clinical Study of EDP-938 for Respiratory Syncytial Virus

Study to evaluate the safety, pharmacokinetics and antiviral activity of multiple doses of orally administered EDP-938 against respiratory syncytial virus infection in a human challenge study.

October 23, 2018
·
6 min read
Business

Millar Completes Exit from Telemetry Product Sales and Transitions to Life Sciences OEM Partnership Model

Millar, Inc. today announces the company will finalize its exit from the life sciences telemetry market on December 31, 2018.

October 23, 2018
·
2 min read
Business

CANbridge Pharmaceutical Inc. and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics

CANbridge Plans to Submit First Rare Disease IND in China in 2019

October 23, 2018
·
3 min read
Business

Lark Health Names Dr. Rosemary Ku Chief Medical Officer

Kaiser, Restore Health Executive to Drive Clinical Leadership

October 23, 2018
·
3 min read
Bausch Health Announces Endowment With The University Of Missouri To Support Student Scholarships

Bausch Health Companies Inc. today announced it has established a permanently endowed scholarship fund at the University of Missouri in the amount of $750,000. The endowment will be used to fund scholarships for students studying in health care related fields.

October 23, 2018
·
1 min read
Pharm Country

Daiichi Sankyo, Inc. Publishes Second Edition of Pain Trends Report

Findings Will Be Presented at Academy of Managed Care Pharmacy (AMCP) Nexus Industry Workshop

October 23, 2018
·
3 min read
FDA

Seqirus Receives FDA Approval of AFLURIA® QUADRIVALENT (Influenza Vaccine) for People Six Months of Age and Older in the U.S.

Seqirus today announced the U.S. Food and Drug Administration (FDA) has approved AFLURIA® QUADRIVALENT (Influenza Vaccine) for use in people six months of age and older,1 extending the company’s broad portfolio of influenza vaccine offerings. The approval also applies to the trivalent formulation of AFLURIA® (Influenza Vaccine).2

October 23, 2018
·
9 min read